Thermo Fisher Reports 22 Percent Revenue Growth for Q2, Raises Guidance for 2018

Jul 25, 2018

|

This article has been updated with additional comments from Thermo Fisher Scientific's earnings call.

NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported a 22 percent increase in second-quarter revenues that was partly driven by acquisitions and increased its revenue and earnings guidance for the year for the second time in a row.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Thermo Fisher Reports 22 Percent Revenue Growth for Q2, Raises Guidance for 2018

To read the full story....

Breaking News

Biden Unveils Economic Plan to Provide $50B for COVID-19 Testing Expansion

Report Details COVID-19 Testing Within Federal Government

In Brief This Week: Yourgene Health, Deep Lens, Canexia Health, and More

DARPA Awards $36.7M to Six Organizations for Gene Editing-Based Dx, Biosurveillance Tech

FDA Grants Emergency Use Authorization for SML Genetree Molecular Coronavirus Test

Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials

What's Popular?

JP Morgan Healthcare Conference, Day 3: Exact Sciences, Luminex, Danaher, Siemens Healthineers, and More

JP Morgan Healthcare Conference 2021, Day One: Roche, Guardant, Hologic, Thermo Fisher, and More

JP Morgan Healthcare Conference, Day 2: Qiagen, LabCorp, Abbott, and More

Digital Pathology Firm Paige Raises $100M in Series C Round

Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials

Sponsorships